A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

NCT01656811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: levalbuterol 90 mcg
DRUG: levalbuterol 180 mcg
DRUG: racemic albuterol 180 mcg
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.